Clinical Trials
358 trialsdOCT-pBCC
Vejle Hospital
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
National Institutes of Health Clinical Center (CC)
TUPRO
University of Zurich
TraveraRTGx
Travera Inc
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
iSITE
The Wellcome Sanger Institute
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
NISSO
Sun Pharmaceutical Industries Limited
LEGIT_MC_EVCDA
AI Labs Group S.L
IMMUMELA
Assistance Publique - Hôpitaux de Paris
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Institute of Oncology Ljubljana
LegitHealth PH
AI Labs Group S.L
LegitHealthSAN
AI Labs Group S.L
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
AI Labs Group S.L
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
Amgen
Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
University of Wisconsin, Madison
TavieSkin
Pierre Fabre Medicament
Precision Medicine for Neurocutaneous Syndromes in Western China
West China Hospital
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
Memorial Sloan Kettering Cancer Center
ICI-PICK
Indiana University
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
Maastricht University Medical Center
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Pharmassist Ltd
FIL_MOGA
Fondazione Italiana Linfomi - ETS
MEL-CARE
Ankara Etlik City Hospital
LEAD Melanoma
Novartis
Portable Measurement of Protoporphyrin IX in the Skin
Dartmouth-Hitchcock Medical Center
DISSEMELA
Assistance Publique - Hôpitaux de Paris
Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques
Centre Hospitalier Universitaire de Nīmes
Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab
Bristol-Myers Squibb
CASE
Regeneron Pharmaceuticals
RNA-OCT-BCC
Bispebjerg Hospital
Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk
University of Alabama at Birmingham
AIQ TRAQinform
AIQ Solutions
SBRT
Mayo Clinic
imMUno
Institut Curie
DELFI-L101
Delfi Diagnostics Inc.
SK-XO
Universitas Sumatera Utara
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
Corewell Health West
BCC-Sonidegib
Federico II University
NICO
Bristol-Myers Squibb
How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.
Skin Analytics Limited
Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation
Case Comprehensive Cancer Center
Skin Barrier and Microbiome of CTCL Patients
Centre for Human Drug Research, Netherlands
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
National Institutes of Health Clinical Center (CC)
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Region Skane
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
Head and Neck Melanoma; Access to Staging and Surgical Treatment
Hull University Teaching Hospitals NHS Trust
OCT and Invasion in Cutaneous Skin Lesions
Maastricht University Medical Center